Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Genomic Health made its Oncotype DX prostate cancer test available recently after a presentation of a positive clinical validation study by the University of California, San Francisco, at this year’s American Urological Association annual meeting.
The Center for Phlebotomy Education is conducting a three-day seminar for those who train or manage phlebotomists. It will take place Nov. 6–8 at the Brown Hotel in Louisville, Ky. The staff of the Center for Phlebotomy Education will conduct the sessions. They are program administrator Catherine Ernst, RN, PBT(ASCP); program coordinator Lisa Steinam, PBT(ASCP); and executive director Dennis J. Ernst, MT(ASCP).
Helmer Scientific’s i.Series and Horizon Series under counter refrigerators and freezers are available in ADA-compatible models. These models are designed to fit under 34-inch ADA-compliant counters and offer chamber temperature uniformity with quick recovery, bacteria-resistant powder coating, and a self-closing door with magnetic latch.
Qiagen is expanding its next-generation sequencing portfolio of nine GeneRead DNAseq panels to about 20 during the course of this year. Qiagen is leveraging its molecular content and assay portfolio to create these new gene panels for targeted NGS analysis based on the GeneGlobe portfolio of more than 60,000 annotated molecular assays.
Primera Technology now offers its chemical- , temperature- , and abrasion-resistant TuffCoat 2 (TC2) high-performance ink ribbons for its Signature Slide Printer. The new ribbon formulations were developed specifically to provide superior performance in pathology, histology, cytology, and other types of laboratory applications.
The FDA has approved GlaxoSmithKline’s Tafinlar (dabrafenib) and Mekinist (trametinib) oral oncology treatments. Tafinlar is indicated as a single-agent oral treatment for unresectable melanoma or metastatic melanoma in adult patients with BRAF V600E mutation.
Milestone Medical’s BoneStation is a dedicated system for standardizing fixation and decalcification of bone specimens. Users can optimize molecular testing results with increased RNA yield from routine cases by combining less aggressive decalcifying solutions with BoneStation’s controlled agitation and temperature management.
Immunodiagnostic Systems has received FDA clearance for its 1,25-dihydroxy vitamin D assay for use on the IDS-iSys system.
The vitamin D test is used to measure 1,25-dihydroxy vitamin D deficiency, which is associated with renal disease and used in the diagnosis of disorders in the metabolism of 25-hydroxyvitamin D and phosphate.
Gold Standard Diagnostics’ new Line Immunoassay technology for Lyme confirmation testing gives clinical laboratories an FDA-cleared option for serological confirmation testing for Lyme disease according to the CDC-recommended two-step process.
Randox Laboratories and Aterovax have announced a strategic partnership to commercialize Aterovax’s secreted phospholipase A2 (sPLA2) biomarker for the assessment of cardiovascular risk.
